Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and Pk/Pd Results for Lead Program Tx45
Tectonic Therapeutic宣佈首個療法Tx45主導項目的1a期安全性、耐受性和藥代動力學/藥效學結果良好
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and Pk/Pd Results for Lead Program Tx45
Tectonic Therapeutic宣佈首個療法Tx45主導項目的1a期安全性、耐受性和藥代動力學/藥效學結果良好
譯文內容由第三人軟體翻譯。